RANBAXY Laboratories has announced that is has received approval from the Australian health regulator to market its anti-fungal tablets in the country.
13/03/2009
STIRLING Products has announced that MilPharma’s Administrators have accepted its offer to purchase the company subject to conditions.
26/06/2009
MERCK Sharp and Dohme has announced its type 2 diabetes therapy, Janumet, has been approved by the Therapeutic Goods Administration (TGA).
27/04/2009
Australia's Therapeutic Goods Administration (TGA) has been closely monitoring any side effects from the use of the Panvax vaccine since its approval for the national immunisation program.
24/11/2009
THE GOVERNMENT hopes to subject homeopathic medicines to tougher regulations under a bill currently before federal parliament.
26/03/2009
BAYER HealthCare and Tsinghua University, Beijing, have signed a comprehensive collaboration agreement to enter into a strategic partnership
19/03/2009
FERNO Australia has announced it has acquired the Australian subsidiary of German medical technology company Weinmann.
15/09/2009
THE THERAPEUTIC Goods Administration (TGA) has approved the world’s first intradermal (ID) influenza vaccine, Intanza, for the prevention of seasonal influenza in adults and the elderly
02/04/2009
The Therapeutic Goods Administration (TGA) has approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza.
04/12/2009
ACCORDING to a study found in the 18 March 2009 issue of the Journal of the American Medical Association, narcolepsy drug modafinil may be addictive.
20/03/2009
Second-round grants under the Medical Devices Financial Incentive Program have been awarded to four companies developing medical devices that improve patient safety and comfort. The funding is to enable local companies to have their innovative devices clinically assessed and trialled.
23/10/2009
University of Wollongong (UOW) researchers have developed a prostate cancer treatment device to enhance a US company’s Prostate Immobilizer Balloon System.
09/11/2009
As at 31 December 2009, of the 6 million doses of Panvax distributed in Australia, there were 1289 suspected side effects reported to the Therapeutic Goods Administration (TGA) following vaccination.
01/03/2010
US researchers have created synthetic molecules that enhance the body’s immune response to the AIDS virus (HIV) and HIV-infected cells. These synthetic molecules could lead to novel therapeutic approaches for AIDS patients.
12/11/2009
The Therapeutic Goods Administration (TGA) has advised on some of the adverse reactions following vaccination with Gardasil, a vaccine against human papilloma virus (HPV).
11/12/2009
Using a molecular imaging technique to study brain cell inflammation may help researchers understand why certain neurological disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide better approaches for treatment.
12/11/2009
US researchers have discovered that a drug currently used for treating Alzheimer's can either improve or worsen the progression of Huntington's disease (HD) depending on where the brain cells it targets are located.
17/11/2009
Roche has announced the latest results of its Phase III clinical trial, CLL8, involving MabThera/Rituxan. The study compared MabThera/Rituxan with two different chemotherapy regimens as first-line treatment of patients with advanced follicular, indolent and mantle cell lymphomas.
10/12/2009